Global Endocrine Testing Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Endocrine Testing Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Test (Thyroid Test, Insulin Test, Human Chorionic Gonadotropin Test, Prolactin Test, Luteinizing Hormone Test, Progesterone Test, and Other Tests), Technology (Immunoassay, Tandem Mass Spectroscopy, Sensor Technology, and Other Technologies), End User (Hospitals, Clinical Laboratories, and Other End Users), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Endocrine Testing Market was valued at USD 2,596.01 million in 2023 and is expected to reach USD 5,249.13 million by 2031 while growing at a CAGR of 9.2% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global endocrine testing market growth. Endocrine testing encompasses diagnostic procedures aimed at evaluating the function of the endocrine system, consisting of glands that release hormones into the bloodstream to regulate diverse physiological processes such as homeostasis, metabolism, growth, development, reproduction, and response to stress.
The increasing prevalence of endocrine disorders, coupled with advancements in diagnostic technologies like immunoassays, chromatography, molecular diagnostics, and point-of-care testing, fuels the growth of the endocrine testing market. Nonetheless, cost constraints and regulatory challenges, along with reimbursement issues, could hinder its further expansion.
Furthermore, the global endocrine testing industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Test Analysis
The Global Endocrine Testing Market is segmented among Thyroid Test, Insulin Test, Human Chorionic Gonadotropin Test, Prolactin Test, Luteinizing Hormone Test, Progesterone Test, and Other Tests, based on Test. In 2023, Insulin Test accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Technology Analysis
The Global Endocrine Testing Market is segmented among Immunoassay, Tandem Mass Spectroscopy, Sensor Technology, and Other Technologies, based on Technology. In 2023, Immunoassay accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Endocrine Testing Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are AB Sciex, Abbott Laboratories, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin SpA, F. Hoffmann-La Roche Ltd, Hologic Inc., and Ortho Clinical Diagnostics
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Endocrine Testing Market Dynamics
Drivers
Restraints
Opportunity
4. Global Endocrine Testing Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Endocrine Testing Market Segmentation, By Test
Global Endocrine Testing Market Share Analysis, By Test
Global Endocrine Testing Market Growth Analysis, By Test
Global Endocrine Testing Market Trends, By Test
o Thyroid Test
o Insulin Test
o Human Chorionic Gonadotropin Test
o Prolactin Test
o Luteinizing Hormone Test
o Progesterone Test
o Other Tests
6. Global Endocrine Testing Market Segmentation, By Technology
Global Endocrine Testing Market Share Analysis, By Technology
Global Endocrine Testing Market Growth Analysis, By Technology
Global Endocrine Testing Market Trends, By Technology
o Immunoassay
o Tandem Mass Spectroscopy
o Sensor Technology
o Other Technologies
7. Global Endocrine Testing Market Segmentation, By End User
Global Endocrine Testing Market Share Analysis, By End User
Global Endocrine Testing Market Growth Analysis, By End User
Global Endocrine Testing Market Trends, By End User
o Hospitals
o Clinical Laboratories
o Other End Users
8. Global Endocrine Testing Market Segmentation, By Region
Global Endocrine Testing Market Share Analysis, By Region
Global Endocrine Testing Market Growth Analysis, By Region
Global Endocrine Testing Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
AB Sciex*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Abbott Laboratories
Agilent Technologies Inc.
bioMerieux SA
Bio-Rad Laboratories Inc.
Danaher Corporation
DiaSorin SpA
F. Hoffmann-La Roche Ltd
Hologic Inc.
Ortho Clinical Diagnostics
*Similar analysis will be provided for each company listed above.
